LSPN Europe 2018: SPCs—important but ‘phenomenally complicated’, say lawyers

16-11-2018

LSPN Europe 2018: SPCs—important but ‘phenomenally complicated’, say lawyers

Supplementary protection certificates (SPCs) are hugely important to MSD’s business, according to Elena Böhles, assistant counsel at the pharmaceutical company, based in Hertfordshire, UK.


LSPN Europe 2018, supplementary protection certificates, manufacturing waiver, Court of Justice of the European Union, generic competition, branded drugs

LSIPR